Last updated on September 2014

Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer


Find a site near you

Start Over

Bayer Clinical Trials Contact

Kowloon, Hong Kong
4.2miles
  Connect »

Bayer Clinical Trials Contact

New Territories, Hong Kong
4.75miles
  Connect »

Bayer Clinical Trials Contact

Hong Kong, Hong Kong
5.77miles
  Connect »